The interim leadership of the CDC held its first all-hands meeting of the Trump administration, and STAT listened in.

This is the online version of our BIO 2025 newsletter. Get more BIO updates directly to your inbox by signing up here, and ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

China is a one of the most important regions for the booming obesity market, thanks to government incentives and changing ...

We are on the cusp of turning the tide against dementia — which makes this an especially bad time to pull back on research.” ...

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products ...

Humana leaders asserted at the company’s investor day Monday that there’s still money to be made on Medicare Advantage ...

Eli Lilly is buying Verve Therapeutics, developer of gene-editing treatments for cardiovascular disease, for $1 billion plus ...

Eli Lilly said Tuesday that it will acquire Verve Therapeutics, a biotech developing gene-editing therapies for cardiovascular disease.

The Medicare pay bump for doctors that was part of the House version of Republicans’ tax bill was dropped in the Senate’s ...

Historically, ACIP has been one of the most transparent federal committees, they wrote, with rigorous reporting on conflicts ...